Alterity Therapeutics Limited (ATHE)

NASDAQ: ATHE · Real-Time Price · USD

4.120

+0.040 (0.98%)

At close: May 29, 2026, 4:00 PM EDT

4.240

+0.120 (2.91%)

After-hours: May 29, 2026, 4:51 PM EDT

Alterity Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 29, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Cap	70	62	16	11	24	45
Market Cap Growth	93.42%	293.56%	39.27%	-53.59%	-45.84%	-100.00%
Enterprise Value	35.09	40.48	7.41	0.91	0.49	24.11
Last Close Price	4.12	4.09	1.81	2.79	6.10	13.00
PS Ratio	15.91	12.38	5.89	4.35	6.92	13.43
PB Ratio	1.95	2.23	1.72	0.75	1.00	1.98
P/TBV Ratio	-	1.03	0.80	0.50	0.69	1.21
EV/Sales Ratio	7.93	8.05	2.76	0.35	0.14	7.17
Debt / Equity Ratio	-	0.00	0.00	0.00	0.00	0.00
Net Debt / Equity Ratio	-	-0.78	-0.90	-0.68	-0.98	-0.92
Net Debt / EBITDA Ratio	-	2.68	0.64	1.07	2.25	1.86
Net Debt / FCF Ratio	-	2.88	0.99	0.78	2.79	1.62
Asset Turnover	-	0.23	0.17	0.11	0.14	0.21
Quick Ratio	-	10.49	3.10	5.58	6.79	10.56
Current Ratio	-	12.98	3.54	6.17	7.07	10.92
Return on Equity (ROE)	-	-42.75%	-103.97%	-46.66%	-38.54%	-81.39%
Return on Assets (ROA)	-	-37.97%	-84.05%	-42.40%	-41.14%	-69.73%
Return on Invested Capital (ROIC)	-	-228.35%	-448.04%	-358.72%	-948.65%	-6599.81%
Return on Capital Employed (ROCE)	-	-44.23%	-106.60%	-50.17%	-46.93%	-80.42%
Buyback Yield / Dilution	-74.72%	-75.31%	-50.29%	-0.91%	-41.79%	-89.62%
Total Shareholder Return	-74.72%	-75.31%	-50.29%	-0.91%	-41.79%	-89.62%

SEC Filings: 10-K · 10-Q